PRNP and scrapie: The first group (high dose) was treated with a relatively high dose of 31.5 ug of bacterially expressed and purified recombinant hamster PrP amino acids 23–231 (HaPrP) via intracerebral injection coincident with the scrapie inoculation and orally with 70 ug of HaPrP the following day.